Study blood clot cell activity in people with a heart pump
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at how your blood’s clot-forming cells (platelets) behave when you have a heart pump device placed (short-term or long-term). The results may help doctors better understand complications and how to manage them after implantation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You are planning to get a heart pump device placed soon (short-term or long-term)
- You may be getting a short-term device such as Impella or ECMO
- Or you may be getting a long-term device such as an LVAD
- You agree to take part in the study (consent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how platelets (the cells that help clot blood) behave in patients on a lung-support machine called ECMO. By taking blood samples, researchers hope to better understand clotting issues that can occur during ECMO support.
This trial tests if taking aspirin along with a standard blood thinner helps people with a HeartMate3 heart pump have fewer bleeding or clotting problems. It is for people who have had their pump for at least 3 months.
This study watches how well platelets (cells that help blood clot) work in people who have high-risk heart surgery using a heart-lung machine for more than 2 hours. The goal is to learn more about bleeding risks after surgery.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
This study tests a temporary heart pump called Phimume® that is inserted through a blood vessel in the leg to help your heart pump blood during a high-risk heart procedure. It is for people with very weak hearts who cannot safely have standard heart surgery.
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.